Recombinant CTLA4 (Botensilimab Biosimilar) antibody

Catalog No. ABIN7597564

The Human Monoclonal anti-CTLA4 (Botensilimab Biosimilar) antibody is suitable to detect CTLA4 (Botensilimab Biosimilar) in samples from Human.

Quick Overview for Recombinant CTLA4 (Botensilimab Biosimilar) antibody (ABIN7597564)

Target: CTLA4 (Botensilimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This CTLA4 (Botensilimab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-CTLA4 (Botensilimab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Botensilimab Biosimilar Antibody

Specificity: CD152, Cytotoxic T-lymphocyte protein 4, CTLA-4, CTLA4, Cytotoxic T-lymphocyte-associated antigen 4

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for CTLA4 (Botensilimab Biosimilar)

Target: CTLA4 (Botensilimab Biosimilar)

Alternative Name: Botensilimab Biosimilar

Target Type: Biosimilar

Background: CD152, Cytotoxic T-lymphocyte protein 4, CTLA-4, CTLA4, Cytotoxic T-lymphocyte-associated antigen 4

UniProt: P16410

CAS-No: 2408310-37-0